Stroke treatment breakthrough? new drug may boost recovery after clot removal
NCT ID NCT06949228
First seen Jan 22, 2026 · Last updated May 16, 2026 · Updated 13 times
Summary
This study tests whether giving a clot-busting drug (tenecteplase) directly into the brain artery after mechanical clot removal can improve recovery in people with severe stroke. About 132 adults aged 18-85 with large artery blockages will be enrolled. The goal is to see if the drug helps more patients achieve near-normal function at 90 days without causing dangerous bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
ProMedica Toledo Hospital
RECRUITINGToledo, Ohio, 43606, United States
Conditions
Explore the condition pages connected to this study.